{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:10:58Z","timestamp":1759032658694},"reference-count":177,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"DOI":"10.3389\/fpsyt.2016.00082","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T03:24:22Z","timestamp":1463541862000},"update-policy":"http:\/\/dx.doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies"],"prefix":"10.3389","volume":"7","author":[{"given":"Th\u00e9r\u00e8se","family":"van Amelsvoort","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis","family":"Hernaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,5,18]]},"reference":[{"issue":"1","key":"B1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1037\/a0028727","article-title":"Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review","volume":"139","author":"Snyder","year":"2013","journal-title":"Psychol Bull"},{"issue":"10","key":"B2","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1017\/S0033291713002535","article-title":"Cognitive impairment in depression: a systematic review and meta-analysis","volume":"44","author":"Rock","year":"2014","journal-title":"Psychol Med"},{"issue":"1","key":"B3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/schbul\/sbp093","article-title":"Cognitive impairment in affective psychoses: a meta-analysis","volume":"36","author":"Bora","year":"2010","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"B4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.schres.2014.06.034","article-title":"Meta-analysis of cognitive performance in drug-naive patients with schizophrenia","volume":"158","author":"Fatouros-Bergman","year":"2014","journal-title":"Schizophr Res"},{"issue":"6","key":"B5","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1017\/S0033291707001675","article-title":"Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives","volume":"38","author":"Arts","year":"2008","journal-title":"Psychol Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2014.06.019","article-title":"A meta-analysis of neuropsychological functioning in first-episode bipolar disorders","volume":"57","author":"Lee","year":"2014","journal-title":"J Psychiatr Res"},{"issue":"3","key":"B7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00213-010-1963-z","article-title":"Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation","volume":"212","author":"Morein-Zamir","year":"2010","journal-title":"Psychopharmacology"},{"issue":"2","key":"B8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1037\/0894-4105.22.2.262","article-title":"Verbal and nonverbal memory processing in patients with obsessive-compulsive disorder: its relationship to clinical variables","volume":"22","author":"Segalas","year":"2008","journal-title":"Neuropsychology"},{"issue":"7","key":"B9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.alcohol.2012.04.005","article-title":"Cognitive functions in abstinent alcohol-dependent patients","volume":"46","author":"Kopera","year":"2012","journal-title":"Alcohol"},{"issue":"1","key":"B10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.2174\/1874473711104010042","article-title":"Drug-related decrease in neuropsychological functions of abstinent drug users","volume":"4","author":"van Holst","year":"2011","journal-title":"Curr Drug Abuse Rev"},{"issue":"3","key":"B11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3109\/08039488.2011.565801","article-title":"A systematic review of neuropsychological performance in social anxiety disorder","volume":"65","author":"O\u2019Toole","year":"2011","journal-title":"Nord J Psychiatry"},{"issue":"3","key":"B12","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.bandc.2009.06.007","article-title":"Executive functions in children with autism spectrum disorders","volume":"71","author":"Robinson","year":"2009","journal-title":"Brain Cogn"},{"issue":"3","key":"B13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s10803-006-0074-5","article-title":"Executive functioning in children with an autism spectrum disorder: can we differentiate within the spectrum?","volume":"36","author":"Verte","year":"2006","journal-title":"J Autism Dev Disord"},{"issue":"6","key":"B14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1089\/cap.2008.064","article-title":"A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder","volume":"18","author":"Joseph","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"B15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.acn.2005.04.005","article-title":"Neuropsychological performance in adult attention-deficit hyperactivity disorder: meta-analysis of empirical data","volume":"20","author":"Schoechlin","year":"2005","journal-title":"Arch Clin Neuropsychol"},{"issue":"6","key":"B16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1001\/archgenpsychiatry.2011.1592","article-title":"Cognitive functioning in prodromal psychosis: a meta-analysis","volume":"69","author":"Fusar-Poli","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"B17","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1017\/S0033291706007896","article-title":"Cognitive function in unaffected twins discordant for affective disorder","volume":"36","author":"Christensen","year":"2006","journal-title":"Psychol Med"},{"issue":"6","key":"B18","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1176\/appi.ajp.160.6.1078","article-title":"Neurobehavioral disinhibition in childhood predicts early age at onset of substance use disorder","volume":"160","author":"Tarter","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"1\u20133","key":"B19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jad.2010.11.011","article-title":"Cognitive impairment in the remitted state of unipolar depressive disorder: a systematic review","volume":"134","author":"Hasselbalch","year":"2011","journal-title":"J Affect Disord"},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40345-015-0024-2","article-title":"Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness","volume":"3","author":"Daglas","year":"2015","journal-title":"Int J Bipolar Disord"},{"issue":"3","key":"B21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/jcpp.12160","article-title":"The persistence of cognitive deficits in remitted and unremitted ADHD: a case for the state-independence of response inhibition","volume":"55","author":"McAuley","year":"2014","journal-title":"J Child Psychol Psychiatry"},{"issue":"8","key":"B22","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1017\/S0033291704002697","article-title":"Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders","volume":"34","author":"Majer","year":"2004","journal-title":"Psychol Med"},{"issue":"1\u20133","key":"B23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jad.2007.04.014","article-title":"Neuropsychological performance predicts clinical recovery in bipolar patients","volume":"105","author":"Gruber","year":"2008","journal-title":"J Affect Disord"},{"issue":"3","key":"B24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1176\/appi.ajp.163.3.418","article-title":"Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms","volume":"163","author":"Bowie","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"3","key":"B25","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10802-009-9369-2","article-title":"Does childhood executive function predict adolescent functional outcomes in girls with ADHD?","volume":"38","author":"Miller","year":"2010","journal-title":"J Abnorm Child Psychol"},{"issue":"1","key":"B26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0165-0327(99)00157-3","article-title":"Executive dysfunction predicts nonresponse to fluoxetine in major depression","volume":"60","author":"Dunkin","year":"2000","journal-title":"J Affect Disord"},{"issue":"6","key":"B27","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/schbul\/sbv120","article-title":"Relationship of cognition to clinical response in first-episode schizophrenia spectrum disorders","volume":"41","author":"Trampush","year":"2015","journal-title":"Schizophr Bull"},{"issue":"10 Pt 1","key":"B28","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/j.neubiorev.2013.03.022","article-title":"Innovative solutions to novel drug development in mental health","volume":"37","author":"Insel","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"B29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.tics.2010.11.002","article-title":"Cognitive enhancement by drugs in health and disease","volume":"15","author":"Husain","year":"2011","journal-title":"Trends Cogn Sci"},{"issue":"8","key":"B30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.biopsych.2013.10.016","article-title":"Effects of stimulants on brain function in attention-deficit\/hyperactivity disorder: a systematic review and meta-analysis","volume":"76","author":"Rubia","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"9","key":"B31","doi-asserted-by":"publisher","first-page":"902","DOI":"10.4088\/JCP.12r08287","article-title":"Effect of psychostimulants on brain structure and function in ADHD: a qualitative literature review of magnetic resonance imaging-based neuroimaging studies","volume":"74","author":"Spencer","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"B32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1017\/S1461145713001594","article-title":"Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies","volume":"17","author":"Linssen","year":"2014","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"B33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JAD-122140","article-title":"A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer\u2019s disease","volume":"35","author":"Di Santo","year":"2013","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"B34","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"B35","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/0269881114542453","article-title":"Efficacy of atomoxetine in adults with attention deficit hyperactivity disorder: an integrated analysis of the complete database of multicenter placebo-controlled trials","volume":"28","author":"Asherson","year":"2014","journal-title":"J Psychopharmacol"},{"issue":"2","key":"B36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00228-013-1600-y","article-title":"Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis","volume":"70","author":"Desamericq","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"B37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3758\/s13415-011-0083-5","article-title":"Meta-analytic evidence for a superordinate cognitive control network subserving diverse executive functions","volume":"12","author":"Niendam","year":"2012","journal-title":"Cogn Affect Behav Neurosci"},{"issue":"12","key":"B38","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1038\/nn1594","article-title":"Cognitive control mechanisms resolve conflict through cortical amplification of task-relevant information","volume":"8","author":"Egner","year":"2005","journal-title":"Nat Neurosci"},{"issue":"24","key":"B39","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1073\/pnas.93.24.13473","article-title":"Regional and cellular fractionation of working memory","volume":"93","author":"Goldman-Rakic","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.pneurobio.2013.06.005","article-title":"Inhibition and impulsivity: behavioral and neural basis of response control","volume":"108","author":"Bari","year":"2013","journal-title":"Prog Neurobiol"},{"issue":"1","key":"B41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/hbm.20127","article-title":"Involvement of the inferior frontal junction in cognitive control: meta-analyses of switching and Stroop studies","volume":"25","author":"Derrfuss","year":"2005","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"B42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neuropsychologia.2007.07.015","article-title":"Meta-analysis of Go\/No-go tasks demonstrating that fMRI activation associated with response inhibition is task-dependent","volume":"46","author":"Simmonds","year":"2008","journal-title":"Neuropsychologia"},{"issue":"2","key":"B43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nlm.2008.09.006","article-title":"Some surprising findings on the involvement of the parietal lobe in human memory","volume":"91","author":"Olson","year":"2009","journal-title":"Neurobiol Learn Mem"},{"issue":"5\u20136","key":"B44","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00429-005-0037-1","article-title":"Functional clusters in the human parietal cortex as revealed by an observer-independent meta-analysis of functional activation studies","volume":"210","author":"Nickel","year":"2005","journal-title":"Anat Embryol"},{"issue":"1","key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1162\/08989290051137585","article-title":"Imaging cognition II: an empirical review of 275 PET and fMRI studies","volume":"12","author":"Cabeza","year":"2000","journal-title":"J Cogn Neurosci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.coph.2013.11.009","article-title":"Increasing pharmacological knowledge about human neurological and psychiatric disorders through functional neuroimaging and its application in drug discovery","volume":"14","author":"Nathan","year":"2014","journal-title":"Curr Opin Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/978-1-61737-992-5_28","article-title":"Pharmacological application of fMRI","volume":"711","author":"Mehta","year":"2011","journal-title":"Methods Mol Biol"},{"issue":"3","key":"B48","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/HRP.0b013e318293749e","article-title":"Areas of the brain modulated by single-dose methylphenidate treatment in youth with ADHD during task-based fMRI: a systematic review","volume":"21","author":"Czerniak","year":"2013","journal-title":"Harv Rev Psychiatry"},{"issue":"2","key":"B49","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12311-011-0260-7","article-title":"The cerebellum and cognition: evidence from functional imaging studies","volume":"11","author":"Stoodley","year":"2012","journal-title":"Cerebellum"},{"issue":"5 Pt 1","key":"B50","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1006\/nimg.2000.0592","article-title":"Distinguishing the functional roles of multiple regions in distributed neural systems for visual working memory","volume":"11","author":"Haxby","year":"2000","journal-title":"Neuroimage"},{"issue":"9","key":"B51","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.tics.2008.05.007","article-title":"Automatic guidance of attention from working memory","volume":"12","author":"Soto","year":"2008","journal-title":"Trends Cogn Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev-psych-010213-115159","article-title":"The nucleus accumbens: an interface between cognition, emotion, and action","volume":"66","author":"Floresco","year":"2015","journal-title":"Annu Rev Psychol"},{"issue":"1","key":"B53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/35036228","article-title":"The prefrontal cortex and cognitive control","volume":"1","author":"Miller","year":"2000","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"B54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/hbm.20131","article-title":"N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies","volume":"25","author":"Owen","year":"2005","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"B55","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3758\/CABN.3.4.255","article-title":"Neuroimaging studies of working memory: a meta-analysis","volume":"3","author":"Wager","year":"2003","journal-title":"Cogn Affect Behav Neurosci"},{"key":"B56","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.neuroimage.2013.10.012","article-title":"Selection and stopping in voluntary action: a meta-analysis and combined fMRI study","volume":"86","author":"Rae","year":"2014","journal-title":"Neuroimage"},{"issue":"7","key":"B57","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"3","key":"B58","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1076\/neur.9.3.274.15563","article-title":"Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study","volume":"9","author":"Nahas","year":"2003","journal-title":"Neurocase"},{"issue":"4","key":"B59","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/01.jcp.0000169267.36797.76","article-title":"Effects of rivastigmine on sustained attention in schizophrenia: an fMRI study","volume":"25","author":"Aasen","year":"2005","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"B60","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.neuroimage.2005.08.013","article-title":"Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study","volume":"29","author":"Kumari","year":"2006","journal-title":"NeuroImage"},{"issue":"11","key":"B61","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.4088\/JCP.09m05504yel","article-title":"Enhanced prefrontal function with pharmacotherapy on a response inhibition task in adolescent bipolar disorder","volume":"71","author":"Pavuluri","year":"2010","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"B62","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.bbr.2011.10.003","article-title":"Pharmacotherapy impacts functional connectivity among affective circuits during response inhibition in pediatric mania","volume":"226","author":"Pavuluri","year":"2012","journal-title":"Behav Brain Res"},{"issue":"3","key":"B63","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.pscychresns.2014.04.011","article-title":"The effects of carbamazepine on prefrontal activation in manic youth with bipolar disorder","volume":"223","author":"Schneider","year":"2014","journal-title":"Psychiatry Res"},{"issue":"11","key":"B64","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.biopsych.2006.12.022","article-title":"A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy","volume":"62","author":"Walsh","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"1","key":"B65","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/JGP.0b013e31817b60af","article-title":"Altered functioning of the executive control circuit in late-life depression: episodic and persistent phenomena","volume":"17","author":"Aizenstein","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"B66","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1503\/jpn.090081","article-title":"Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression","volume":"35","author":"Wagner","year":"2010","journal-title":"J Psychiatry Neurosci"},{"issue":"4","key":"B67","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.biopsych.2015.02.037","article-title":"Frontoparietal activation during response inhibition predicts remission to antidepressants in patients with major depression","volume":"79","author":"Gyurak","year":"2016","journal-title":"Biol Psychiatry"},{"issue":"1","key":"B68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.euroneuro.2006.04.012","article-title":"Spatial working memory in obsessive-compulsive disorder improves with clinical response: a functional MRI study","volume":"17","author":"van der Wee","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"issue":"5","key":"B69","doi-asserted-by":"publisher","first-page":"665","DOI":"10.3346\/jkms.2011.26.5.665","article-title":"Altered brain activation in ventral frontal-striatal regions following a 16-week pharmacotherapy in unmedicated obsessive-compulsive disorder","volume":"26","author":"Han","year":"2011","journal-title":"J Korean Med Sci"},{"issue":"12","key":"B70","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1176\/appi.ajp.162.12.2322","article-title":"Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment","volume":"162","author":"Snitz","year":"2005","journal-title":"Am J Psychiatry"},{"issue":"8","key":"B71","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s00406-006-0687-x","article-title":"Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation","volume":"256","author":"Meisenzahl","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"1","key":"B72","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pscychresns.2008.06.003","article-title":"An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia","volume":"172","author":"Keedy","year":"2009","journal-title":"Psychiatry Res"},{"issue":"2","key":"B73","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/schbul\/sbu071","article-title":"Impact of antipsychotic treatment on attention and motor learning systems in first-episode schizophrenia","volume":"41","author":"Keedy","year":"2015","journal-title":"Schizophr Bull"},{"issue":"2","key":"B74","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.pscychresns.2013.09.010","article-title":"Subcortical modulation of attentional control by second-generation antipsychotics in first-episode psychosis","volume":"221","author":"Ikuta","year":"2014","journal-title":"Psychiatry Res"},{"issue":"1","key":"B75","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3109\/10826084.2014.957771","article-title":"Cognitive control network function in alcohol use disorder before and during treatment with lorazepam","volume":"50","author":"Wilcox","year":"2015","journal-title":"Subst Use Misuse"},{"issue":"3","key":"B76","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.drugalcdep.2013.09.003","article-title":"Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study","volume":"133","author":"Ashare","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"11","key":"B77","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.euroneuro.2013.07.008","article-title":"A proof of concept study of tolcapone for pathological gambling: relationships with COMT genotype and brain activation","volume":"23","author":"Grant","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"issue":"8","key":"B78","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.biopsych.2010.01.016","article-title":"Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers","volume":"67","author":"Loughead","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"4","key":"B79","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/npp.2009.196","article-title":"Functional magnetic resonance imaging of effects of a nicotinic agonist in schizophrenia","volume":"35","author":"Tregellas","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"B80","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.biopsych.2010.07.004","article-title":"Effects of an alpha 7-nicotinic agonist on default network activity in schizophrenia","volume":"69","author":"Tregellas","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"9","key":"B81","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1001\/archgenpsychiatry.2011.2053","article-title":"Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit\/hyperactivity disorder","volume":"69","author":"Schulz","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"B82","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pscychresns.2012.09.004","article-title":"Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit\/hyperactivity disorder: a pilot study","volume":"211","author":"Bush","year":"2013","journal-title":"Psychiatry Res"},{"issue":"12","key":"B83","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.euroneuro.2015.08.024","article-title":"Differential therapeutic effects of 12-week treatment of atomoxetine and methylphenidate on drug-naive children with attention deficit\/hyperactivity disorder: a counting Stroop functional MRI study","volume":"25","author":"Chou","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"B84","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/jcp.0b013e318161318f","article-title":"A pilot study of adjunctive atomoxetine treatment to second-generation antipsychotics for cognitive impairment in schizophrenia","volume":"28","author":"Friedman","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"B85","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pscychresns.2015.01.012","article-title":"Neural mechanisms underlying the therapeutic actions of guanfacine treatment in youth with ADHD: a pilot fMRI study","volume":"231","author":"Bedard","year":"2015","journal-title":"Psychiatry Res"},{"issue":"23\u201324","key":"B86","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.drudis.2013.09.005","article-title":"Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer\u2019s disease","volume":"18","author":"Melancon","year":"2013","journal-title":"Drug Discov Today"},{"issue":"Pt B","key":"B87","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuropharm.2014.10.021","article-title":"The nicotinic cholinergic system function in the human brain","volume":"96","author":"Nees","year":"2015","journal-title":"Neuropharmacology"},{"issue":"8","key":"B88","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.pnpbp.2008.08.001","article-title":"A 12-week, double-blind, placebo-controlled trial of donepezil adjunctive treatment to risperidone in chronic and stable schizophrenia","volume":"32","author":"Akhondzadeh","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"B89","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/01.WNF.0000240940.67241.F6","article-title":"Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study","volume":"30","author":"Fagerlund","year":"2007","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"B90","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s00213-005-2235-1","article-title":"Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial","volume":"181","author":"Freudenreich","year":"2005","journal-title":"Psychopharmacology"},{"issue":"5","key":"B91","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0006-3223(01)01342-7","article-title":"A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia","volume":"51","author":"Friedman","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"2","key":"B92","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1017\/S1461145703004024","article-title":"A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia","volume":"7","author":"Tugal","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Pt 1","key":"B93","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/brain\/awh671","article-title":"Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation \u2013 a pharmacological fMRI study","volume":"129","author":"Goekoop","year":"2006","journal-title":"Brain"},{"issue":"5\u20136","key":"B94","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000435948","article-title":"Long-term response to cholinesterase inhibitor treatment is related to functional MRI response in Alzheimer\u2019s disease","volume":"40","author":"Miettinen","year":"2015","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"B95","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/1531-8249(200004)47:4470::AID-ANA103.0.CO;2-M","article-title":"Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study","volume":"47","author":"Pihlajamaki","year":"2000","journal-title":"Ann Neurol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3389\/fpsyg.2014.00772","article-title":"What do verbal fluency tasks measure? Predictors of verbal fluency performance in older adults","volume":"5","author":"Shao","year":"2014","journal-title":"Front Psychol"},{"issue":"Pt 9","key":"B97","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1093\/brain\/awp176","article-title":"Modulation of fusiform cortex activity by cholinesterase inhibition predicts effects on subsequent memory","volume":"132","author":"Bentley","year":"2009","journal-title":"Brain"},{"issue":"6","key":"B98","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ana.23874","article-title":"Cholinergic enhancement of functional networks in older adults with mild cognitive impairment","volume":"73","author":"Pa","year":"2013","journal-title":"Ann Neurol"},{"issue":"4","key":"B99","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2165\/11530260-000000000-00000","article-title":"Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature","volume":"24","author":"Ribeiz","year":"2010","journal-title":"CNS Drugs"},{"issue":"1","key":"B100","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0006-3223(94)00252-X","article-title":"Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia","volume":"38","author":"Freedman","year":"1995","journal-title":"Biol Psychiatry"},{"issue":"3","key":"B101","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1176\/appi.ajp.2011.11020189","article-title":"Lower ss2*-nicotinic acetylcholine receptor availability in smokers with schizophrenia","volume":"169","author":"D\u2019Souza","year":"2012","journal-title":"Am J Psychiatry"},{"issue":"1","key":"B102","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1176\/appi.ajp.160.1.118","article-title":"In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia","volume":"160","author":"Raedler","year":"2003","journal-title":"Am J Psychiatry"},{"key":"B103","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/j.1749-6632.1999.tb11335.x","article-title":"Desensitization of nicotinic receptors in the central nervous system","volume":"868","author":"Fenster","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"B104","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1124\/jpet.102.041756","article-title":"Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors","volume":"304","author":"Gentry","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"B105","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.biopsych.2013.11.001","article-title":"In vivo evidence for beta2 nicotinic acetylcholine receptor subunit upregulation in smokers as compared with nonsmokers with schizophrenia","volume":"76","author":"Esterlis","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"2","key":"B106","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/S0006-8993(02)03570-9","article-title":"Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism","volume":"956","author":"Ichikawa","year":"2002","journal-title":"Brain Res"},{"issue":"23","key":"B107","doi-asserted-by":"publisher","first-page":"13432","DOI":"10.1073\/pnas.96.23.13432","article-title":"Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia","volume":"96","author":"Honey","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20133","key":"B108","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.schres.2010.01.022","article-title":"Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation","volume":"118","author":"Schlagenhauf","year":"2010","journal-title":"Schizophr Res"},{"issue":"10","key":"B109","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.biopsych.2014.12.021","article-title":"Neurobiological impact of nicotinic acetylcholine receptor agonists: an activation likelihood estimation meta-analysis of pharmacologic neuroimaging studies","volume":"78","author":"Sutherland","year":"2015","journal-title":"Biol Psychiatry"},{"issue":"2","key":"B110","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.biopsych.2008.08.028","article-title":"Varenicline improves mood and cognition during smoking abstinence","volume":"65","author":"Patterson","year":"2009","journal-title":"Biol Psychiatry"},{"issue":"2","key":"B111","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00213-012-2700-6","article-title":"The effects of varenicline on attention and inhibitory control among treatment-seeking smokers","volume":"223","author":"Rhodes","year":"2012","journal-title":"Psychopharmacology"},{"issue":"1","key":"B112","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1037\/a0025594","article-title":"Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers","volume":"20","author":"Ashare","year":"2012","journal-title":"Exp Clin Psychopharmacol"},{"issue":"3","key":"B113","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/npp.2012.205","article-title":"Effects of short-term varenicline administration on emotional and cognitive processing in healthy, non-smoking adults: a randomized, double-blind, study","volume":"38","author":"Mocking","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"B114","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1176\/appi.ajp.2008.07071135","article-title":"Initial phase 2 trial of a nicotinic agonist in schizophrenia","volume":"165","author":"Freedman","year":"2008","journal-title":"Am J Psychiatry"},{"issue":"1","key":"B115","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1097\/01.pra.0000442935.15833.c5","article-title":"Normalizing effects of EVP-6124, an alpha-7 nicotinic partial agonist, on event-related potentials and cognition: a proof of concept, randomized trial in patients with schizophrenia","volume":"20","author":"Preskorn","year":"2014","journal-title":"J Psychiatr Pract"},{"issue":"12","key":"B116","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1001\/archgenpsychiatry.2011.83","article-title":"Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder","volume":"68","author":"Hong","year":"2011","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"B117","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/npp.2011.238","article-title":"Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial","volume":"37","author":"Shim","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"B118","doi-asserted-by":"publisher","first-page":"e0143490","DOI":"10.1371\/journal.pone.0143490","article-title":"Varenicline effects on smoking, cognition, and psychiatric symptoms in schizophrenia: a double-blind randomized trial","volume":"11","author":"Smith","year":"2016","journal-title":"PLoS One"},{"issue":"1\u20133","key":"B119","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.schres.2009.02.001","article-title":"Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder","volume":"110","author":"Smith","year":"2009","journal-title":"Schizophr Res"},{"issue":"1\u20133","key":"B120","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.schres.2013.06.032","article-title":"Varenicline modulates spatial working memory deficits in smokers with schizophrenia","volume":"149","author":"Wing","year":"2013","journal-title":"Schizophr Res"},{"issue":"3","key":"B121","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1460-9568.2009.06613.x","article-title":"Alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex","volume":"29","author":"Livingstone","year":"2009","journal-title":"Eur J Neurosci"},{"issue":"8","key":"B122","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.bcp.2007.07.032","article-title":"The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum","volume":"74","author":"Grady","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"50","key":"B123","doi-asserted-by":"publisher","first-page":"11244","DOI":"10.1523\/JNEUROSCI.3009-04.2004","article-title":"Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area","volume":"24","author":"Jones","year":"2004","journal-title":"J Neurosci"},{"issue":"8","key":"B124","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jaac.2011.05.011","article-title":"Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysis","volume":"50","author":"Liu","year":"2011","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1\u20132","key":"B125","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2009.10.033","article-title":"Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis","volume":"122","author":"Smith","year":"2010","journal-title":"J Affect Disord"},{"issue":"1","key":"B126","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/npp.2011.181","article-title":"From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment","volume":"37","author":"Moghaddam","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"B127","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.brainres.2004.09.016","article-title":"Effects of acute and chronic lamotrigine treatment on basal and stimulated extracellular amino acids in the hippocampus of freely moving rats","volume":"1029","author":"Ahmad","year":"2004","journal-title":"Brain Res"},{"issue":"2\u20133","key":"B128","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.eplepsyres.2005.02.002","article-title":"Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids","volume":"63","author":"Ahmad","year":"2005","journal-title":"Epilepsy Res"},{"issue":"1","key":"B129","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/0006-8993(92)91038-G","article-title":"The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus: an in vivo microdialysis study","volume":"594","author":"Biggs","year":"1992","journal-title":"Brain Res"},{"issue":"4","key":"B130","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/BF00967253","article-title":"Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain","volume":"18","author":"Loscher","year":"1993","journal-title":"Neurochem Res"},{"issue":"7","key":"B131","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/sj.mp.4001087","article-title":"Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity","volume":"7","author":"Farber","year":"2002","journal-title":"Mol Psychiatry"},{"issue":"12","key":"B132","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1016\/j.euroneuro.2015.09.020","article-title":"Anterior cingulate glutamate-glutamine cycle metabolites are altered in euthymic bipolar I disorder","volume":"25","author":"Soeiro-de-Souza","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"issue":"11","key":"B133","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.4088\/JCP.13r08767","article-title":"Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature","volume":"75","author":"Spencer","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"B134","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jaac.2012.03.009","article-title":"Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study","volume":"51","author":"Strawn","year":"2012","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"B135","doi-asserted-by":"publisher","first-page":"yv082","DOI":"10.1093\/ijnp\/pyv082","article-title":"The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials","volume":"19","author":"Rosenblat","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1\u20132","key":"B136","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jad.2008.10.028","article-title":"Cognitive inhibition and working memory in unipolar depression","volume":"116","author":"Gohier","year":"2009","journal-title":"J Affect Disord"},{"issue":"8","key":"B137","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.euroneuro.2013.05.005","article-title":"The role of 5-HT in response inhibition and re-engagement","volume":"23","author":"Drueke","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuroimage.2015.08.012","article-title":"Single-dose serotonergic stimulation shows widespread effects on functional brain connectivity","volume":"122","author":"Klaassens","year":"2015","journal-title":"Neuroimage"},{"issue":"6","key":"B139","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/npp.2012.264","article-title":"Serotonin 2A receptors, citalopram and tryptophan-depletion: a multimodal imaging study of their interactions during response inhibition","volume":"38","author":"Macoveanu","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"B140","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/sj.mp.4001894","article-title":"Prefrontal hyperactivation during working memory task in untreated individuals with major depressive disorder","volume":"12","author":"Matsuo","year":"2007","journal-title":"Mol Psychiatry"},{"issue":"6 Suppl","key":"B141","doi-asserted-by":"publisher","first-page":"24S","DOI":"10.1097\/00004714-198712001-00003","article-title":"Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression","volume":"7","author":"Blier","year":"1987","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"B142","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1177\/026988110001400208","article-title":"Serotonin autoreceptor function and antidepressant drug action","volume":"14","author":"Hjorth","year":"2000","journal-title":"J Psychopharmacol"},{"issue":"3","key":"B143","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/hbm.20035","article-title":"Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain","volume":"22","author":"Varnas","year":"2004","journal-title":"Hum Brain Mapp"},{"issue":"2","key":"B144","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.neuroscience.2005.11.033","article-title":"Distribution of norepinephrine transporters in the non-human primate brain","volume":"138","author":"Smith","year":"2006","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"B145","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0006-8993(09)90010-5","article-title":"Localization and gene expression of serotonin 1A (5HT1A) receptors in human brain postmortem","volume":"658","author":"Marazziti","year":"1994","journal-title":"Brain Res"},{"key":"B146","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.neuropsychologia.2014.01.023","article-title":"Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks","volume":"56","author":"Nandam","year":"2014","journal-title":"Neuropsychologia"},{"issue":"4","key":"B147","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1097\/00001756-199703030-00048","article-title":"Cingulate function in depression: a potential predictor of treatment response","volume":"8","author":"Mayberg","year":"1997","journal-title":"Neuroreport"},{"issue":"3","key":"B148","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/archpsyc.57.3.249","article-title":"Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia","volume":"57","author":"Purdon","year":"2000","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"B149","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1017\/S1461145705005924","article-title":"Influence of atypical neuroleptics on executive functioning in patients with schizophrenia: a randomized, double-blind comparison of olanzapine vs. clozapine","volume":"9","author":"Bender","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"B150","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/npp.2009.192","article-title":"Treatment with olanzapine is associated with modulation of the default mode network in patients with schizophrenia","volume":"35","author":"Sambataro","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"B151","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/BF02245607","article-title":"Risperidone: regional effects in vivo on release and metabolism of dopamine and serotonin in the rat brain","volume":"124","author":"Hertel","year":"1996","journal-title":"Psychopharmacology"},{"issue":"5","key":"B152","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1046\/j.1471-4159.2001.00154.x","article-title":"5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release","volume":"76","author":"Ichikawa","year":"2001","journal-title":"J Neurochem"},{"issue":"3","key":"B153","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0006-3223(00)00850-7","article-title":"5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex","volume":"48","author":"Rollema","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"6","key":"B154","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/jnc.12512","article-title":"Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism","volume":"128","author":"Huang","year":"2014","journal-title":"J Neurochem"},{"issue":"3","key":"B155","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s002130050834","article-title":"The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors","volume":"141","author":"Zhang","year":"1999","journal-title":"Psychopharmacology"},{"issue":"8","key":"B156","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s40263-013-0082-x","article-title":"Effect of tolcapone on brain activity during a variable attentional control task: a double-blind, placebo-controlled, counter-balanced trial in healthy volunteers","volume":"27","author":"Magalona","year":"2013","journal-title":"CNS Drugs"},{"issue":"5","key":"B157","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1038\/sj.npp.1301227","article-title":"Tolcapone improves cognition and cortical information processing in normal human subjects","volume":"32","author":"Apud","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"B158","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.1600-0773.1999.tb02014.x","article-title":"Microdialysis studies on the action of tolcapone on pharmacologically-elevated extracellular dopamine levels in conscious rats","volume":"85","author":"Huotari","year":"1999","journal-title":"Pharmacol Toxicol"},{"issue":"2\u20133","key":"B159","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0014-2999(98)00524-X","article-title":"No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats","volume":"356","author":"Li","year":"1998","journal-title":"Eur J Pharmacol"},{"issue":"23","key":"B160","doi-asserted-by":"publisher","first-page":"5331","DOI":"10.1523\/JNEUROSCI.1124-04.2004","article-title":"Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex","volume":"24","author":"Tunbridge","year":"2004","journal-title":"J Neurosci"},{"issue":"5","key":"B161","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"10","key":"B162","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1523\/JNEUROSCI.21-10-03628.2001","article-title":"Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons","volume":"21","author":"Seamans","year":"2001","journal-title":"J Neurosci"},{"issue":"10","key":"B163","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jaac.2010.06.015","article-title":"Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors","volume":"49","author":"Gamo","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"B164","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/j.1471-4159.2010.06750.x","article-title":"Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice","volume":"114","author":"Koda","year":"2010","journal-title":"J Neurochem"},{"issue":"1","key":"B165","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.schres.2004.12.019","article-title":"Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers","volume":"77","author":"Barch","year":"2005","journal-title":"Schizophr Res"},{"issue":"4","key":"B166","doi-asserted-by":"publisher","first-page":"518","DOI":"10.4088\/JCP.08m04358","article-title":"A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia","volume":"70","author":"Kelly","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"B167","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.biopsych.2011.01.027","article-title":"Catecholamine influences on dorsolateral prefrontal cortical networks","volume":"69","author":"Arnsten","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"10","key":"B168","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1016\/j.euroneuro.2014.08.001","article-title":"Guanfacine for attention deficit and hyperactivity disorder in pediatrics: a systematic review and meta-analysis","volume":"24","author":"Ruggiero","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"B169","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1177\/0269881114562091","article-title":"A translational investigation targeting stress-reactivity and prefrontal cognitive control with guanfacine for smoking cessation","volume":"29","author":"McKee","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"31","key":"B170","doi-asserted-by":"publisher","first-page":"13040","DOI":"10.1073\/pnas.0905267106","article-title":"Correspondence of the brain\u2019s functional architecture during activation and rest","volume":"106","author":"Smith","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"B171","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1093\/cercor\/bhs136","article-title":"Dopamine-dependent architecture of cortico-subcortical network connectivity","volume":"23","author":"Cole","year":"2013","journal-title":"Cereb Cortex"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-015-9468-8","article-title":"Hints on the lateralization of dopamine binding to D1 receptors in rat striatum","author":"Franco","year":"2015","journal-title":"Mol Neurobiol"},{"issue":"1","key":"B173","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00429-012-0492-4","article-title":"Cerebral serotonin transporter asymmetry in females, males and male-to-female transsexuals measured by PET in vivo","volume":"219","author":"Kranz","year":"2014","journal-title":"Brain Struct Funct"},{"issue":"9","key":"B174","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00702-009-0265-2","article-title":"Hemispheric lateralization of the corticostriatal glutamatergic system in the rat","volume":"116","author":"Capper-Loup","year":"2009","journal-title":"J Neural Transm (Vienna)"},{"issue":"11","key":"B175","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00213-014-3813-x","article-title":"Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey","volume":"232","author":"Vardigan","year":"2015","journal-title":"Psychopharmacology"},{"issue":"21\u201322","key":"B176","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1007\/s00213-015-4008-9","article-title":"Dissociable effects of NR2A and NR2B NMDA receptor antagonism on cognitive flexibility but not pattern separation","volume":"232","author":"Kumar","year":"2015","journal-title":"Psychopharmacology"},{"issue":"2","key":"B177","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1124\/jpet.115.226910","article-title":"Evidence for classical cholinergic toxicity associated with selective activation of M1 muscarinic receptors","volume":"356","author":"Alt","year":"2016","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T19:44:28Z","timestamp":1567885468000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fpsyt.2016.00082\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,18]]},"references-count":177,"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2016.00082","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,18]]}}}